Salvage chemotherapy of biweekly irinotecan plus S-1 (biweekly IRIS) in previously treated patients with advanced gastric cancer期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

Salvage chemotherapy of biweekly irinotecan plus S-1 (biweekly IRIS) in previously treated patients with advanced gastric cancer

Authors:	Hong Jae Chon,Sun Young Rha,Hyung Soon Park,Sang Joon Shin,Hyo Song Kim,Jae Kyung Roh,Sung Hoon Noh,Hyun Cheol Chung,Hei-Cheul Jeung authors-affiliations__indexes u-inline-list" data-role=" AuthorsIndexes" >

Affiliation:	(1) Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea;(2) Division of Oncology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea;(3) Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea;(4) Cancer Metastasis Research Center, Yonsei University College of Medicine, Seoul, Korea;(5) Department of Surgery, Yonsei University College of Medicine, Seoul, Korea;(6) Division of Oncology, Department of Internal Medicine, Gangnam Severance Hospital, Yonsei Cancer Center, Yonsei University College of Medicine, 712, Eonju-Ro (146-92, Dogok-Dong), Gangnam-Gu, Seoul, 135-720, Korea;

Abstract:	Purpose This phase II trial first describes the combination chemotherapy of biweekly irinotecan plus S-1 (biweekly IRIS) for pretreated advanced gastric cancer (AGC) patients.

Keywords:
本文献已被 PubMed SpringerLink 等数据库收录！